What is BridgeBio Pharma's gross profit?

BridgeBio Pharma (BBIO) reported gross profit of $184.58M in Q1 2026.

How has BridgeBio Pharma's gross profit changed year-over-year?

BridgeBio Pharma's gross profit increased by 61.9% year-over-year, from $113.99M to $184.58M.

What is the long-term trend for BridgeBio Pharma's gross profit?

Over 4 years (2021 to 2025), BridgeBio Pharma's gross profit has grown at a 63.7% compound annual growth rate (CAGR), from $66.98M to $481.11M.

BridgeBio Pharma BBIO Gross Profit

Gross Profit at other companies

PfizerPFE

$10.9B+0.3%

Bristol-Myers SquibbBMY

$8.07B-1.2%

Ionis PharmaceuticalsIONS

——

BioMarin PharmaceuticalsBMRN

——

ALN

Alnylam PharmaceuticalsALNY

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$194.5M+66.8%

Operating income-$106.0M-1.5%

Net income-$166.6M+1.8%

EPS (diluted)-$0.84+4.5%

Balance sheet

See full

Cash & equivalents$882.0M+62.5%

Total debt$3.3B+32,101%

Total equity-$2.3B-38.2%

Total assets$1.4B+55.5%

Cash flow

See full

Operating cash flow-$197.3M+1.0%

CapEx$69.0K—

Free cash flow-$197.3M+0.9%

Valuation

See full

Market cap$12.98B+119%

Enterprise value$15.36B+178%

P/S22.4×-24.1×

Profitability

See full

Gross margin95.1%-0.2pp

Operating margin-90.5%-41.2pp

Net margin-125.9%-54.5pp

FCF margin-76.8%—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity2×—

Current ratio1.5×-3.0×

Where this comes from

Calculated from BridgeBio Pharma’s reported figures.

$194.5Mtotal revenue−$9.9Mtotal cost of revenue=$184.58M

The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BridgeBio Pharma's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BridgeBio Pharma's gross profit?: BridgeBio Pharma (BBIO) reported gross profit of $184.58M in Q1 2026.
How has BridgeBio Pharma's gross profit changed year-over-year?: BridgeBio Pharma's gross profit increased by 61.9% year-over-year, from $113.99M to $184.58M.
What is the long-term trend for BridgeBio Pharma's gross profit?: Over 4 years (2021 to 2025), BridgeBio Pharma's gross profit has grown at a 63.7% compound annual growth rate (CAGR), from $66.98M to $481.11M.